Business Segments Bruker Corporation
Equities
BRKR
US1167941087
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.67 USD | +1.20% |
|
-0.72% | -22.09% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
BSI Nano | 556M | 698M | 787M | 942M | 1.1B | |||||
CAPEX | -10.6M | -16.8M | -20.2M | -13.9M | -19.3M | |||||
D&A | 35.7M | 37.4M | 35.6M | 48M | 61.7M | |||||
Operating Income | 23.6M | 73.4M | 113M | 109M | 124M | |||||
BSI CALID | - | - | 822M | 960M | 1.09B | |||||
CAPEX | - | - | -33.9M | -31.4M | -34.1M | |||||
D&A | - | - | 20.7M | 29.3M | 67M | |||||
Operating Income | - | - | 196M | 209M | 246M | |||||
BSI Bio Spin | - | - | 697M | 798M | 906M | |||||
CAPEX | - | - | -14.5M | -23.9M | -22.8M | |||||
D&A | - | - | 22.6M | 25.7M | 41M | |||||
Operating Income | - | - | 167M | 196M | 217M | |||||
BSI Life Science | 1.25B | 1.51B | - | - | - | |||||
CAPEX | -59.1M | -61.3M | - | - | - | |||||
D&A | 35M | 41.1M | - | - | - | |||||
Operating Income | 274M | 385M | - | - | - | |||||
Total Assets | 2.96B | 3.56B | 3.51B | 4.11B | 5.65B | |||||
Electrical Apparatus | ||||||||||
Bruker Energy & Supercon Technologies (BEST) | 190M | 224M | 237M | 281M | 283M | |||||
Total Assets | 88.7M | 97.9M | 111M | 186M | 200M | |||||
CAPEX | -10.1M | -9.2M | -51.5M | -27.5M | -24.3M | |||||
D&A | 5.7M | 6.3M | 6M | 7.2M | 8.4M | |||||
Operating Income | 6.2M | 22.2M | 31.3M | 32.3M | 35.1M | |||||
Corporate | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | -17.4M | -4.7M | -9.1M | -10.2M | -14.8M | |||||
D&A | 4M | 4.3M | 3.9M | 4.7M | 5.7M | |||||
Operating Income | - | - | - | - | - | |||||
Eliminations | -12M | -14M | -12.3M | -17M | -14.1M | |||||
Operating Income | -55.3M | -67.7M | -74.7M | -110M | 104M | |||||
Total Assets | -4.2M | -8.4M | -7.7M | -46.7M | -41.5M | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Bruker Scientific Instruments (BSI) | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 456M | 601M | 696M | 778M | 938M | |||||
Total Assets | 61.3M | 51.3M | 58.8M | 125M | 188M | |||||
Europe Excluding Germany | 520M | 658M | 592M | 700M | 873M | |||||
Total Assets | 145M | 142M | 141M | 57.4M | 91.8M | |||||
Asia Pacific Excluding China | - | - | 408M | 461M | 518M | |||||
Total Assets | - | - | - | 127M | 134M | |||||
China | - | - | 396M | 528M | 471M | |||||
Germany | 245M | 263M | 247M | 282M | 311M | |||||
Total Assets | 228M | 244M | 310M | 350M | 370M | |||||
Other | 138M | 167M | 190M | 217M | 254M | |||||
Total Assets | 7.1M | 6.6M | 6.7M | 9.9M | 8.7M | |||||
Asia Pacific | 629M | 729M | - | - | - | |||||
Total Assets | 22.1M | 22.6M | 22.1M | 22.1M | 22.2M |
- Stock Market
- Equities
- BRKR Stock
- Financials Bruker Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
